MedPath

四川明欣药业有限责任公司

Ownership
-
Established
1998-09-15
Employees
-
Market Cap
-
Website
http://www.scmx.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

29

NMPA:29

Drug Approvals

Imiquimod Cream

Product Name
明欣利迪
Approval Number
国药准字H20030129
Approval Date
Apr 7, 2024
NMPA

Imiquimod Cream

Product Name
明欣利迪
Approval Number
国药准字H20030128
Approval Date
Apr 7, 2024
NMPA

Rifapentine Capsules

Product Name
利福喷丁胶囊
Approval Number
国药准字H10840004
Approval Date
Mar 22, 2024
NMPA

Famciclovir Capsules

Product Name
明立欣
Approval Number
国药准字H19991045
Approval Date
Nov 30, 2023
NMPA

Valacyclovir Hydrochloride Capsules

Product Name
明竹欣
Approval Number
国药准字H10970071
Approval Date
Nov 30, 2023
NMPA

Valaciclovir Hydrochloride Granules

Product Name
明竹欣
Approval Number
国药准字H20010451
Approval Date
Nov 30, 2023
NMPA

Valaciclovir Hydrochloride Granules

Product Name
明竹欣
Approval Number
国药准字H20010450
Approval Date
Nov 30, 2023
NMPA

Valacyclovir Hydrochloride Tablets

Product Name
明竹欣
Approval Number
国药准字H10960202
Approval Date
Nov 30, 2023
NMPA

Hydrocortisone Butyrate Gream

Product Name
丁酸氢化可的松乳膏
Approval Number
国药准字H20074168
Approval Date
Aug 16, 2022
NMPA

Tacrolimus Ointment

Product Name
他克莫司软膏
Approval Number
国药准字H20123430
Approval Date
Jul 13, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.